Arguments for a New Formulation of Liposomal Amphotericin B: An Historical Perspective
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 1 (4), 503-510
- https://doi.org/10.3109/08982109009036011
Abstract
Dr. Armstrong's expert knowledge and vast experience with amphotericin B have allowed him to speak previously with authority on its merits and demerits. According to his assessment, amphotericin B is a valuable drug, marred by severe toxicity. I shall attempt to explain, in this short presentation, why liposomes as vehicles in which to administer amphotericin B have the potential to redress this agent's principal deficiency.Keywords
This publication has 8 references indexed in Scilit:
- Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary StudyThe Journal of Infectious Diseases, 1985
- Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis1American Review of Respiratory Disease, 1982
- POLYENE MAGROLIDE DERIVATIVES. IIThe Journal of Antibiotics, 1972
- Comparative responses of mammalian erythrocytes and microbial protoplasts to polyene antibiotics and vitamin AArchives of Biochemistry and Biophysics, 1963
- The lytic effect of polyene antifungal antibiotics on mammalian erythrocytesBiochemical and Biophysical Research Communications, 1962
- NYSTATIN BINDING BY PROTOPLASTS AND A PARTICULATE FRACTION OF NEUROSPORA CRASSA, AND A BASIS FOR THE SELECTIVE TOXICITY OF POLYENE ANTIFUNGAL ANTIBIOTICSProceedings of the National Academy of Sciences, 1962
- The effect of polyene antibiotics on permeability in NeurosporacrassaBiochemical and Biophysical Research Communications, 1961
- Protection of Fungi against Polyene Antibiotics by SterolsScience, 1958